Skip to main content

Table 2 Assessment of risk of bias and heterogeneity within and across the included studies

From: Genomic analyses of early peri-implant bone healing in humans: a systematic review

Category

Ivanovski et al. [ 34 ]

Donos et al. 2011 [ 35 ]

Bryington et al. [ 36 ]

Thalji et al. [ 37 ]

Study design

  Comparison

None (only SLActive)

SLA vs. SLActive

TiOBlast vs. Osseospeed

TiOBlast vs. Osseospeed

  Setting

University

University

University

University

  Population, inclusion criteria

9 healthy volunteers with no mandibular third molars, no contraindications for oral surgery; age 21 to 48, median 29 years

9 healthy volunteers with no mandibular third molars; age 21 to 48, median 29 years

6 women, 4 men; implant patients, systemically healthy (no HTN, diabetes, CVD); age 25 to 58, mean 36.2 years

9 women, 2 men; implant patients, systemically healthy; age 47 to 69, mean 60.2 years

  Exclusion criteria

Smokers

Smokers

Smokers, pregnancy, periodontal/periapical disease, subjects taking bisphosphonates, hormone replacement therapy, corticosteroids

Smokers, uncontrolled diabetes, history of head/neck radiotherapy, taking corticosteroids, bisphosphonates

  Comparability of groups

Unclear

Unclear

Unclear

Unclear

  Potential confounders, e.g., post-op medication

Unclear

Unclear

Unclear

Unclear

  Power calculation

No

No

No

No

  Statistical correction

For multiple sampling

For multiple sampling

Unclear

For multiple sampling

Methods

  Tissue analyzed

Peri-implant tissue

Peri-implant tissue

Implant-adherent cells

Implant-adherent cells

  Genetic material analyzed

Total RNA

Total RNA

Total RNA

Total RNA

  Success rate

Unclear

16/18 samples (88.8%)

7/10 subject samples (70%)

Unclear

  Genotyping method

Microarray

Microarray

RT-PCR

Whole-genome microarray

  Genotype counts

Yes

Yes

Yes

Yes

  Blinding

Unclear

Unclear

Yes

Unclear

  Reproducibility, validated genotyping accuracy

No

No

No

No

  1. All studies were judged to be at a high risk of bias with substantial heterogeneity across studies.